Translational Research Program
Investigators:
Jane Buckner, MD, Associate Member, Program Director
John Ravits, MD, Research Associate Scientist
Kris Kowdley, MD
Heather Shilling, PhD, Manager, Sequencing and Genotyping Core
Brad Stone, PhD, Research Assistant Member
Karen Cerosaletti, PhD, Staff Scientist
Clinician Investigators at Virginia Mason Medical Center:
Mariko Kita, MD - Multiple Sclerosis
John Ravits, MD - Degenerative Neurologic Diseases
Anthony Gerbino, MD- Pulmonary Diseases
James Lord, MD, PhD - Inflammatory Bowel and Gastrointestinal Diseases
Kris Kowdley, MD – Hepatology
David Robinson, MD – Allergy Immunology
Laboratories:
Buckner Laboratory
Stone Laboratory
Core Facilities:
Array Core Laboratory
Clinical Core Laboratory
Sequencing and Genotyping Core Laboratory
The research emphasis of the BRI Translational Research Program is the area of immune mediated diseases. This includes the study of autoimmune and allergic diseases. The diseases that are being actively studied at this time include:
Type 1 Diabetes
Rheumatic Diseases with an emphasis on those diseases listed below:
- Relapsing polychondritis
- Rheumatoid Arthritis Link to Studies of the Etiology of Rheumatoid Arthritis (SERA)
- Scleroderma
- Systemic Lupus Erythematosus
Pulmonary Disease
- Asthma
- Scleroderma
- Idiopathic Pulmonary Fibrosis
- Sarcoidosis
Gastrointestinal Disease
- Ulcerative Colitis
- Crohn's Disease
- Hepatology
Neurologic Disease
- Multiple Sclerosis
- ALS or Lou Gehrig's Disease
Allergy
The Translational Research Program includes a group of Clinical Coordinators who interface with research participants, a Clinical Core Laboratory which handles and track all samples obtained from individuals, then transfers samples to the research laboratories.
Translational Research Program Group
Jane Buckner, MD
Christine Chan
Ami Charmley
Thien-Son Nguyen
Mark Bramlett
Rachel Rogers
Kate DeGraaff
Bert Park
Heather Shilling, PhD
Katherine Nickel
Amber Matheny
Jennifer Heaton
Kevin Criste